NACA - a new antioxidant to cure and prevent eye disorders
The scientists have developed a new antioxidant that
not only prevents but also cures cataracts, macular degeneration and other eye
disorders.
Dr. Nuran Ercal with other researchers, at the Missouri
University of Science and Technology are examining the eye drops prepared with the
antioxidant Nacetylcysteine amide (NACA) to treat the above mentioned eye
conditions.
According to Ercal, NACA is an improvement over
another experimental treatment – antioxidant Nacetylcysteine (NAC), because is
passes more easily across cell membranes allowing to be used in lower doses.
NACA characteristic is an improvement of NAC achieved
by neutralizing the carboxylic group of NAC which makes the NACA pas cellular
membranes easily.
The new drug can be administered at a lower dose and
has a greater therapeutic index. It also lowers the risk of side effects
associated with NAC.
NACA is an excellent source of Glutathione which is
the cells main antioxidant power which diminishes during degenerative eye
disorders.
About 30 million people in the US alone suffer from
vision loss due to age related eye disorders. This figure will double in the
coming decades, stated Ercal.
Eye drops prepared by NACA will drastically reduce the
costs and will be an excellent alternative to expensive surgeries. It will also
improve the quality of life to those who are afflicted.
The research team lead by Ercal has been testing NACA
on HIV related problems, lead poisoning and other toxicities for about 10
years. Since 4 years they have been testing on eye disorders.
Further testing on NACA solution will help understand
appropriate dosage and frequency and other side effects.
No comments:
Post a Comment